General Updates

Shilpa Medicare Limited Corporate & Admin Office: “Shilpa House”, # 12-6-214/A-1, Hyderabad Road, Raichur – 584 135, Karnataka, India Tel: +91-8532-238704, Fax: +91-8532-238876 Email: info@vbshilpa.com, Web: www.vbshilpa.com CIN: L85110KA1987PLC008739 Date: 10th October 2026 Corporate relationship Department, National Stock Exchange of India, Limited BSE Limited, Exchange Plaza, 5th Floor, 1st Floor, Rotunda Building Plot No. C/1, G Block, Bandra-Kurla Complex, P.J Towers Dalal Street, Fort, Bandra (E), Mumbai 400001 Mumbai 400051 Stock Code: BSE – 530549 / NSE – SHILPAMED Dear Sir/Ma’am, SUB: Europe GMP Approval of Shilpa Medicare Ltd. Unit 4, Jadcherla, Telangana. REF: Intimation under regulation 30 of SEBI (LODR) Regulations 2015. This is to inform you that Shilpa Medicare Limited, Unit 4, Jadcherla, Telangana, India was inspected by AGES, Austria from 27 July, 2026 until 30 July, 2026. Following a successful inspection, the Unit has been issued GMP Certification from AGES, Austria. This Unit of Shilpa Medicare is engaged in the manufacturing, testing and distribution of sterile Injections and non-sterile tablets and Capsule finished dosage forms in Europe and rest of the world markets. For SHILPA MEDICARE LIMITED Ritu Tiwary Company Secretary & Compliance Officer